6-amino-1-hydroxyhexane-1,1-diphosphonate and Hyperparathyroidism, Primary

6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Hyperparathyroidism, Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adami, S; Braga, V; Dhangana, R; Fracassi, E; Gatti, D; Kalpakcioglu, B; Rossini, M; Viapiana, O	1

Other Studies

1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Hyperparathyroidism, Primary

Article	Year
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism. Calcified tissue international, 2011, Volume: 89, Issue:1 Topics: Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Cholecalciferol; Collagen Type I; Diphosphonates; Female; Femur Neck; Humans; Hyperparathyroidism, Primary; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; Time	2011

Article

Year

Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism.

Calcified tissue international, 2011, Volume: 89, Issue:1

Topics: Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Cholecalciferol; Collagen Type I; Diphosphonates; Female; Femur Neck; Humans; Hyperparathyroidism, Primary; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptides; Time

2011